Pensionfund Sabic adds Zimmer Biomet Holdings Inc (ZBH) to its portfolio

Zimmer Biomet Holdings Inc (ZBH) : Pensionfund Sabic added new position in Zimmer Biomet Holdings Inc during the most recent quarter end. The investment management firm now holds 15,000 shares of Zimmer Biomet Holdings Inc which is valued at $1,899,300 , the company said in a statement filed on Oct 12, 2016 with the SEC.Zimmer Biomet Holdings Inc makes up approximately 0.59% of Pensionfund Sabic’s portfolio.

Other Hedge Funds, Including , Canandaigua National Bank Trust Co reduced its stake in ZBH by selling 3 shares or 0.07% in the most recent quarter. The Hedge Fund company now holds 4,250 shares of ZBH which is valued at $538,135. Zimmer Biomet Holdings Inc makes up approx 0.16% of Canandaigua National Bank Trust Co’s portfolio.Catawba Capital Management Va boosted its stake in ZBH in the latest quarter, The investment management firm added 641 additional shares and now holds a total of 43,899 shares of Zimmer Biomet Holdings Inc which is valued at $5,750,769. Zimmer Biomet Holdings Inc makes up approx 1.38% of Catawba Capital Management Va’s portfolio.Central Bank Trust Co boosted its stake in ZBH in the latest quarter, The investment management firm added 15,687 additional shares and now holds a total of 31,996 shares of Zimmer Biomet Holdings Inc which is valued at $4,191,476. Zimmer Biomet Holdings Inc makes up approx 1.19% of Central Bank Trust Co’s portfolio.North Star Asset Management Inc reduced its stake in ZBH by selling 950 shares or 7.25% in the most recent quarter. The Hedge Fund company now holds 12,147 shares of ZBH which is valued at $1,585,791. Zimmer Biomet Holdings Inc makes up approx 0.18% of North Star Asset Management Inc’s portfolio.Cullinan Associates Inc boosted its stake in ZBH in the latest quarter, The investment management firm added 100 additional shares and now holds a total of 25,280 shares of Zimmer Biomet Holdings Inc which is valued at $3,300,304. Zimmer Biomet Holdings Inc makes up approx 0.28% of Cullinan Associates Inc’s portfolio.

Zimmer Biomet Holdings Inc closed down -6.12 points or -4.61% at $126.62 with 21,82,265 shares getting traded on Tuesday. Post opening the session at $132.31, the shares hit an intraday low of $125.57 and an intraday high of $132.31 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Zimmer Biomet Holdings Inc reported $2.02 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.97. The company had revenue of $1934.00 million for the quarter, compared to analysts expectations of $1898.18 million. The company’s revenue was up 65.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.58 EPS.

Many Wall Street Analysts have commented on Zimmer Biomet Holdings Inc. SunTrust Initiated Zimmer Biomet Holdings Inc on Aug 11, 2016 to “Buy”, Price Target of the shares are set at $155.Company shares were Reiterated by Needham on Jul 29, 2016 to “Buy”, Firm has raised the Price Target to $ 150 from a previous price target of $143 .Company shares were Reiterated by Needham on Jul 18, 2016 to “Buy”, Firm has raised the Price Target to $ 143 from a previous price target of $134 .

Zimmer Biomet Holdings Inc. formerly Zimmer Holdings Inc. is a musculoskeletal healthcare company. The Company designs manufactures and markets orthopedic reconstructive products; sports medicine biologics extremities and trauma products; spine bone healing craniomaxillofacial and thoracic products; dental implants and related surgical products. The Company manages its operations through three geographic segments: the Americas comprising principally of the United States and includes other North Central and South American markets; Europe comprising principally of Europe and includes the Middle East and African markets; and Asia Pacific comprising primarily of Japan and includes other Asian and Pacific markets. The Company markets and sells products through three channels: direct to healthcare institutions such as hospitals or direct channel accounts; through stocking distributors and healthcare dealers and directly to dental practices and dental laboratories.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Zimmer Biomet Holdings Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Zimmer Biomet Holdings Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.